Data / Form D filings / Solace Therapeutics Inc
Solace Therapeutics Inc: Form D filings
Solace Therapeutics Inc, a health care company in Framingham, MA, filed 5 Form D notices with the SEC between 2012 and 2021. The latest, on February 9, 2021, reports $6.5 million sold of a $17.6 million offering to 8 investors.
Find out what Solace Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 135 NEWBURY STREET, Framingham, MA, 01701
- Phone
- (508) 283-1200
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1371796
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Amendment | $17,602,367 | $6,527,367 | $11,075,000 | 8 | Jan 30, 2020 | sec.gov |
| Feb 12, 2020 | New notice | $17,550,000 | $4,002,367 | $13,547,633 | 5 | Jan 30, 2020 | sec.gov |
| Feb 11, 2019 | New notice | $2,114,965 | $1,900,000 | $214,965 | 6 | Jan 31, 2019 | sec.gov |
| Sep 6, 2016 | New notice | $20,000,000 | $13,000,000 | $7,000,000 | 2 | Aug 23, 2016 | sec.gov |
| Mar 28, 2012 | New notice | $20,000,000 | $7,000,000 | $13,000,000 | 0 | Mar 14, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William H. Gruber | Executive Officer, Director | |
| Kevin G. Connors | Director | |
| Brian R. Smith | Director | |
| John R. McDonough | Director | |
| David R. Neustaedter | Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
- REVBIO, INC. $15 million · Oct 2, 2026
- Fresenius Medical Care Will Clayton, LLC $3.8 million · Sep 21, 2026
- DynamiCare Health, Inc. $720,000 · Sep 10, 2026
- OnPoint Surgical, Inc. $18 million · Sep 1, 2026
Every Form D from the week of Feb 8, 2021 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Solace Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.